Whole Genome Amplification Market

Whole Genome Amplification Market: Advent of Lysing Techniques & Primer Technologies to Advocate Preference for Single-cell WGA: Analysis 2013 - 2017 and Opportunity Assessment 2018 - 2028

Ask The Analyst Customization Available Request Methodology

Preference for single-cell whole genome amplification to prevail

Single-cell whole genome amplification is the highly preferred product type in the global market. Advances in primer technologies and lysing techniques have led to more reliable andaccurate whole cell genome amplification. Single cell WGA is used to examine the sequence information with the optimized next generation sequencing technologies, only from a single cell. This method is considered to be a powerful tool that helps to understand the ins and outs of genetics by bringing the entire genome structure to a cellular level. Since this method offers a high-resolution view of the genomic sample, its adoption will continue to be on the rise in diverse biological fields such as microbiology, immunology, neurobiology, cancer research, and tissue mosaicism.

Single cell WGA plays a crucial role in conveying new applications to the market. Moreover, screening for a variety of developmental and neurological genetic disorders is heavily dependent on single-cell WGA. These experiments are conducted with an RT-PCR utilizing specific WGA PCR kits. GenomePlex WGA4 kits from Sigma-Aldrich are among a few kits on the market specifically designed for single-cell WGA. Most other kits can be used for either single cells or, more commonly, pool of cells. Leading companies that are dealing in single-cell kits are Sigma-Aldrich (in association with Rubicon Genomics), QIAGEN NV, and GE Healthcare.

According to the market forecast recently provided by Future Market Insights, single-cell WGA Kits are projected to reach a market value of over US$ 2,000 Mn by the end of 2028.

whole-genome-amplification-market.jpg

Device & kits manufacturers to abide by FDA’s safety legislations to improve accuracy and efficiency

There is an increase in the safety rules and legislations which is expected to improve accuracy and efficiency significantly. It is also intended to avoid false positivity of whole genome amplification and boost the quality of diagnostic services. To focus more on safety, the U.S. FDA has provided a guideline such as 510-K. This section of Food Drug and Cosmetic Act, also known as Pre-market Approval, recommends device and kits manufacturers to mandatorily register and notify FDA of their intent to promote their product at least 90 days in advance. These improvements are projected to bolster the growth of the global whole genome amplification market.

Introduction of custom product offerings to hit market, as a new strategic move

The research community has to cater to evolving needs, which in turn requires manufacturing of special custom products. The demand for specialized tools and reagents has grown to the point where most vendors currently offering these products cannot depend solely on the sale of the catalog products. The custom requirements demand special time management which depends on the vendor choices. Research users tend to prefer tried-and-tested solutions for their custom reagent needs to avoid the time and effort to validate custom products prior to use in critical experiments.

Product recalls and safety concerns may deter market growth

The process of WGA involves extraction, amplification and sequencing. The PCR-based WGA andREPLI-g technology have different results. Single base-pair mutations, STR contractions, and expansions, and also biased and underrepresented loci are involved in PCR WGA. Whereas, REPLI-g technology, which uses MDA technology and Phi 29 polymerase, delivers highly uniform amplification across the entire genome with minimal locus bias during amplification. This leads to a lack of trust on the process, which declines the revenue of whole genome amplification market.

Global Whole Genome Amplification Market

The global Whole genome amplification market report provides analysis and insights on Whole genome amplification kits and consumables. Commercially available Whole genome amplification kits are based on Single cell WGA kits, Complete WGA Kit, WGA Reamplification Kit, WGA & Chip DNA Kit and others. Increasing demand for technologically advanced methods in sample preparation, extraction, amplification and testing for nucleic acid and the strategic agreements of manufacturers with leading research institutes to boost research activities in molecular biology field play a vital role for fueling the demand of Whole genome amplification. These Whole genome amplification kits can be used in both clinical diagnostics as well as for research applications. Applications such as agricultural and veterinary animal cell DNA testing, viral and bacterial infectious diseases, drug discovery & development, cancerous diseases, forensic testing, genetically related diseases and paternity testing/HLA typing coupled with rising awareness is predicted to increase usages of whole genome amplification worldwide. This is expected to bolster growth of the Whole genome amplification market over the forecast period.

Global Healthcare Sector Outlook

Despite the economic and political uncertainty in the recent past, the global healthcare industry has been receiving positive nudges from reformative and technological disruptions in medical devices, pharmaceuticals and biotech, in-vitro diagnostics, and medical imaging. Key markets across the world are facing a massive rise in demand for critical care services that are pushing global healthcare spending levels to unimaginable limits.

A rapidly multiplying geriatric population; increasing prevalence of chronic ailments such as cancer and cardiac disease; growing awareness among patients; and heavy investments in clinical innovation are just some of the factors that are impacting the performance of the global healthcare industry. Proactive measures such as healthcare cost containment, primary care delivery, innovation in medical procedures (3-D printing, blockchain, and robotic surgery to name a few), safe and effective drug delivery, and well-defined healthcare regulatory compliance models are targeted at placing the sector on a high growth trajectory across key regional markets.

Research Methodology

FMI utilizes a triangulation methodology that is primarily based on experimental techniques such as patient-level data, to obtain precise market estimations and insights on Molecule and Drug Classes, API Formulations and preferred modes of administration. Bottom-up approach is always used to obtain insightful data for the specific country/regions. The country specific data is again analysed to derive data at a global level. This methodology ensures high quality and accuracy of information.

Secondary research is used at the initial phase to identify the age specific disease epidemiology, diagnosis rate and treatment pattern, as per disease indications. Each piece of information is eventually analysed during the entire research project which builds a strong base for the primary research information.

Primary research participants include demand-side users such as key opinion leaders, physicians, surgeons, nursing managers, clinical specialists who provide valuable insights on trends and clinical application of the drugs, key treatment patterns, adoption rate, and compliance rate.

Quantitative and qualitative assessment of basic factors driving demand, economic factors/cycles and growth rates and strategies utilized by key players in the market is analysed in detail while forecasting, in order to project Year-on-Year growth rates. These Y-o-Y growth projections are checked and aligned as per industry/product lifecycle and further utilized to develop market numbers at a holistic level.

On the other hand, we also analyse various companies annual reports, investor presentations, SEC filings, 10k reports and press release operating in this market segment to fetch substantial information about the market size, trends, opportunity, drivers, restraints and to analyse key players and their market shares. Key companies are segmented at Tier level based on their revenues, product portfolio and presence.

Please note that these are the partial steps that are being followed while developing the market size. Besides this, forecasting will be done based on our internal proprietary model which also uses different macro-economic factors such as per capita healthcare expenditure, disposable income, industry based demand driving factors impacting the market and its forecast trends apart from disease related factors.

Market Taxonomy

 By Product Type

By Application

By End User

By Region

  • Single Cell WGA Kit

  • Complete WGA Kit

  • WGA Reamplification Kit

  • WGA & Chip DNA Kit

  • Others

  • Drug Discovery & Development

  • Disease Diagnosis

  • Agriculture & Veterinary

  • Research

  • Forensics

  • Others

  • Pharma & Biotech Companies

  • Hospitals & Clinics

  • Contract Research

  • Organizations

  • Research & Academic Institutes

  • Others

  • North America

  • Latin America

  • Western Europe

  • Eastern Europe

  • APEJ

  • MEA

  • Japan

Whole Genome Amplification Market Reports - Table of Contents

1. Executive Summary

1.1. Market Overview

1.2. Market Analysis

1.3. FMI Analysis and Recommendations

1.4. Wheel of Fortune

2. Market Introduction

2.1. Market Taxonomy

2.2. Market Definition

2.3. Company Description and Whole Genome Amplification Market Research Coverage

3. Whole Genome Amplification Market Opportunity Analysis

3.1. Macro-Economic Factors

3.2. Opportunity Analysis

4. Global Economic Outlook

4.1. Whole Genome Amplification Market Outlook

5. Market Background

5.1. Technology Evolution

5.2. List of Growth Hacking Manufacturers

5.3. Market Dynamics

5.3.1. Drivers

5.3.2. Restraints

5.4. Regulatory Scenario

6. Macroeconomic Assumptions

7. Key Inclusions

7.1. Usage Trend in Whole Genome Amplification Industry

8. North America Whole Genome Amplification Market Analysis 2013–2017 and Forecast 2018–2028

8.1. Introduction

8.2. Regional Market Trends

8.3. Historical Market Size (US$ Mn) Analysis By Country, 2013-2017

8.3.1. U.S.

8.3.2. Canada

8.4. Market Size (US$ Mn) Forecast By Country, 2018-2028

8.5. Historical Market Size (US$ Mn) Trend Analysis By Product Type, 2013-2017

8.5.1. Single Cell WGA Kit

8.5.2. Complete WGA Kit

8.5.3. WGA Reamplification Kit

8.5.4. WGA and ChIP DNA Kit

8.5.5. DNA Amplification Kit

8.5.6. Others

8.6. Market Size (US$ Mn) Forecast By Product Type, 2018-2028

8.7. Historical Market Size (US$ Mn) Trend Analysis By Application, 2013-2017

8.7.1. Drug Discovery and Development

8.7.2. Disease Diagnosis

8.7.3. Agriculture and Veterinary Research

8.7.4. Forensics

8.7.5. Others

8.8. Market Size (US$ Mn) Forecast By Application, 2018-2028

8.9. Historical Market Size (US$ Mn) Trend Analysis By End User, 2013-2017

8.9.1. Pharmaceutical and Biotechnology Companies

8.9.2. Hospitals and Clinics

8.9.3. Contract Research Organization

8.9.4. Research and Academic Institutes

8.9.5. Others

8.10. Market Size (US$ Mn) Forecast By End User, 2018-2028

8.11. Drivers and Restraints: Impact Analysis

8.12. Market Attractiveness Analysis

8.12.1. By Country

8.12.2. By Product Type

8.12.3. By Application

8.12.4. By End User

8.13. Key Market Participants – Intensity Mapping

8.14. Key Mergers & Acquisitions

9. Western Europe Whole Genome Amplification Market Analysis 2013–2017 and Forecast 2018–2028

9.1. Introduction

9.2. Regional Market Trends

9.3. Historical Market Size (US$ Mn) Analysis By Country, 2013-2017

9.3.1. Germany

9.3.2. U.K

9.3.3. France

9.3.4. Italy

9.3.5. Spain

9.3.6. Rest of Western Europe

9.4. Market Size (US$ Mn) Forecast By Country, 2018-2028

9.5. Historical Market Size (US$ Mn) Trend Analysis By Product Type, 2013-2017

9.5.1. Single Cell WGA Kit

9.5.2. Complete WGA Kit

9.5.3. WGA Reamplification Kit

9.5.4. WGA and ChIP DNA Kit

9.5.5. DNA Amplification Kit

9.5.6. Others

9.6. Market Size (US$ Mn) Forecast By Product Type, 2018-2028

9.7. Historical Market Size (US$ Mn) Trend Analysis By Application, 2013-2017

9.7.1. Drug Discovery and Development

9.7.2. Disease Diagnosis

9.7.3. Agriculture and Veterinary Research

9.7.4. Forensics

9.7.5. Others

9.8. Market Size (US$ Mn) Forecast By Application, 2018-2028

9.9. Historical Market Size (US$ Mn) Trend Analysis By End User, 2013-2017

9.9.1. Pharmaceutical and Biotechnology Companies

9.9.2. Hospitals and Clinics

9.9.3. Contract Research Organization

9.9.4. Research and Academic Institutes

9.9.5. Others

9.10. Market Size (US$ Mn) Forecast By End User, 2018-2028

9.11. Drivers and Restraints: Impact Analysis

9.12. Market Attractiveness Analysis

9.12.1. By Country

9.12.2. By Product Type

9.12.3. By Application

9.12.4. By End User

9.13. Key Market Participants – Intensity Mapping

9.14. Key Mergers & Acquisitions

10. Eastern Europe Whole Genome Amplification Market Analysis 2013–2017 and Forecast 2018–2028

10.1. Introduction

10.2. Regional Market Trends

10.3. Historical Market Size (US$ Mn) Analysis By Country, 2013-2017

10.3.1. Russia

10.3.2. Poland

10.3.3. Rest of Eastern Europe

10.4. Market Size (US$ Mn) Forecast By Country, 2018-2028

10.5. Historical Market Size (US$ Mn) Trend Analysis By Product Type, 2013-2017

10.5.1. Single Cell WGA Kit

10.5.2. Complete WGA Kit

10.5.3. WGA Reamplification Kit

10.5.4. WGA and ChIP DNA Kit

10.5.5. DNA Amplification Kit

10.5.6. Others

10.6. Market Size (US$ Mn) Forecast By Product Type, 2018-2028

10.7. Historical Market Size (US$ Mn) Trend Analysis By Application, 2013-2017

10.7.1. Drug Discovery and Development

10.7.2. Disease Diagnosis

10.7.3. Agriculture and Veterinary Research

10.7.4. Forensics

10.7.5. Others

10.8. Market Size (US$ Mn) Forecast By Application, 2018-2028

10.9. Historical Market Size (US$ Mn) Trend Analysis By End User, 2013-2017

10.9.1. Pharmaceutical and Biotechnology Companies

10.9.2. Hospitals and Clinics

10.9.3. Contract Research Organization

10.9.4. Research and Academic Institutes

10.10. Market Size (US$ Mn) Forecast By End User, 2018-2028

10.11. Drivers and Restraints: Impact Analysis

10.12. Market Attractiveness Analysis

10.12.1. By Country

10.12.2. By Product Type

10.12.3. By Application

10.12.4. By End User

10.13. Key Market Participants – Intensity Mapping

10.14. Key Mergers & Acquisitions

11. Latin America Whole Genome Amplification Market Analysis 2013–2017 and Forecast 2018–2028

11.1. Introduction

11.2. Regional Market Trends

11.3. Historical Market Size (US$ Mn) Analysis By Country, 2013-2017

11.3.1. Brazil

11.3.2. Mexico

11.3.3. Rest of Latin America

11.4. Market Size (US$ Mn) Forecast By Country, 2018-2028

11.5. Historical Market Size (US$ Mn) Trend Analysis By Product Type, 2013-2017

11.5.1. Single Cell WGA Kit

11.5.2. Complete WGA Kit

11.5.3. WGA Reamplification Kit

11.5.4. WGA and ChIP DNA Kit

11.5.5. DNA Amplification Kit

11.5.6. Others

11.6. Market Size (US$ Mn) Forecast By Product Type, 2018-2028

11.7. Historical Market Size (US$ Mn) Trend Analysis By Application, 2013-2017

11.7.1. Drug Discovery and Development

11.7.2. Disease Diagnosis

11.7.3. Agriculture and Veterinary Research

11.7.4. Forensics

11.7.5. Others

11.8. Market Size (US$ Mn) Forecast By Application, 2018-2028

11.9. Historical Market Size (US$ Mn) Trend Analysis By End User, 2013-2017

11.9.1. Pharmaceutical and Biotechnology Companies

11.9.2. Hospitals and Clinics

11.9.3. Contract Research Organization

11.9.4. Research and Academic Institutes

11.9.5. Others

11.10. Market Size (US$ Mn) Forecast By End User, 2018-2028

11.11. Drivers and Restraints: Impact Analysis

11.12. Market Attractiveness Analysis

11.12.1. By Country

11.12.2. By Product Type

11.12.3. By Application

11.12.4. By End User

11.13. Key Market Participants – Intensity Mapping

11.14. Key Mergers & Acquisitions

12. Asia Pacific Excluding Japan Whole Genome Amplification Market Analysis 2013–2017 and Forecast 2018–2028

12.1. Introduction

12.2. Regional Market Trends

12.3. Historical Market Size (US$ Mn) Analysis By Country, 2013-2017

12.3.1. China

12.3.2. India

12.3.3. Australia and New Zealand

12.3.4. ASEAN

12.3.5. Rest of APECJ

12.4. Market Size (US$ Mn) Forecast By Country, 2018-2028

12.5. Historical Market Size (US$ Mn) Trend Analysis By Product Type, 2013-2017

12.5.1. Single Cell WGA Kit

12.5.2. Complete WGA Kit

12.5.3. WGA Reamplification Kit

12.5.4. WGA and ChIP DNA Kit

12.5.5. DNA Amplification Kit

12.5.6. Others

12.6. Market Size (US$ Mn) Forecast By Product Type, 2018-2028

12.7. Historical Market Size (US$ Mn) Trend Analysis By Application, 2013-2017

12.7.1. Drug Discovery and Development

12.7.2. Disease Diagnosis

12.7.3. Agriculture and Veterinary Research

12.7.4. Forensics

12.7.5. Others

12.8. Market Size (US$ Mn) Forecast By Application, 2018-2028

12.9. Historical Market Size (US$ Mn) Trend Analysis By End User, 2013-2017

12.9.1. Pharmaceutical and Biotechnology Companies

12.9.2. Hospitals and Clinics

12.9.3. Contract Research Organization

12.9.4. Research and Academic Institutes

12.9.5. Others

12.10. Market Size (US$ Mn) Forecast By End User, 2018-2028

12.11. Drivers and Restraints: Impact Analysis

12.12. Market Attractiveness Analysis

12.12.1. By Country

12.12.2. By Product Type

12.12.3. By Application

12.12.4. By End User

12.13. Key Market Participants – Intensity Mapping

12.14. Key Mergers & Acquisitions

13. Japan Whole Genome Amplification Market Analysis 2013–2017 and Forecast 2018–2028

13.1. Introduction

13.2. Regional Market Trends

13.3. Historical Market Size (US$ Mn) Trend Analysis By Product Type, 2013-2017

13.3.1. Single Cell WGA Kit

13.3.2. Complete WGA Kit

13.3.3. WGA Reamplification Kit

13.3.4. WGA and ChIP DNA Kit

13.3.5. DNA Amplification Kit

13.3.6. Others

13.4. Market Size (US$ Mn) Forecast By Product Type, 2018-2028

13.5. Historical Market Size (US$ Mn) Trend Analysis By Application, 2013-2017

13.5.1. Drug Discovery and Development

13.5.2. Disease Diagnosis

13.5.3. Agriculture and Veterinary Research

13.5.4. Forensics

13.5.5. Others

13.6. Market Size (US$ Mn) Forecast By Application, 2018-2028

13.7. Historical Market Size (US$ Mn) Trend Analysis By End User, 2013-2017

13.7.1. Pharmaceutical and Biotechnology Companies

13.7.2. Hospitals and Clinics

13.7.3. Contract Research Organization

13.7.4. Research and Academic Institutes

13.7.5. Others

13.8. Market Size (US$ Mn) Forecast By End User, 2018-2028

13.9. Drivers and Restraints: Impact Analysis

13.10. Market Attractiveness Analysis

13.10.1. By Product Type

13.10.2. By Application

13.10.3. By End User

13.11. Key Market Participants – Intensity Mapping

13.12. Key Mergers & Acquisitions

14. Middle East and Africa Whole Genome Amplification Market Analysis 2013–2017 and Forecast 2018–2028

14.1. Introduction

14.2. Regional Market Trends

14.3. Historical Market Size (US$ Mn) Analysis By Country, 2013-2017

14.3.1. GCC Countries

14.3.2. South Africa

14.3.3. Rest of Middle East and Africa

14.4. Market Size (US$ Mn) Forecast By Country, 2018-2028

14.5. Historical Market Size (US$ Mn) Trend Analysis By Product Type, 2013-2017

14.5.1. Single Cell WGA Kit

14.5.2. Complete WGA Kit

14.5.3. WGA Reamplification Kit

14.5.4. WGA and ChIP DNA Kit

14.5.5. DNA Amplification Kit

14.5.6. Others

14.6. Market Size (US$ Mn) Forecast By Product Type, 2018-2028

14.7. Historical Market Size (US$ Mn) Trend Analysis By Application, 2013-2017

14.7.1. Drug Discovery and Development

14.7.2. Disease Diagnosis

14.7.3. Agriculture and Veterinary Research

14.7.4. Forensics

14.7.5. Others

14.8. Market Size (US$ Mn) Forecast By Application, 2018-2028

14.9. Historical Market Size (US$ Mn) Trend Analysis By End User, 2013-2017

14.9.1. Pharmaceutical and Biotechnology Companies

14.9.2. Hospitals and Clinics

14.9.3. Contract Research Organization

14.9.4. Research and Academic Institutes

14.9.5. Others

14.10. Market Size (US$ Mn) Forecast By End User, 2018-2028

14.11. Drivers and Restraints: Impact Analysis

14.12. Market Attractiveness Analysis

14.12.1. By Country

14.12.2. By Product Type

14.12.3. By Application

14.12.4. By End User

14.13. Key Market Participants – Intensity Mapping

14.14. Key Mergers & Acquisitions

15. Forecast Factors: Relevance and Impact

16. Forecast Assumptions

17. Market Structure Analysis

17.1.Market Structure by Tier of Companies

17.2.Market Share Analysis (2017) for Top 10 Players, By Region

17.3.Production Capacity Analysis, By Key Players

17.4.Pricing Analysis By Key Players, By Region

18. Competition Analysis

18.1. Competition Dashboard

18.2. Competition Benchmarking

18.3. Profitability and Gross Margin Analysis By Competition

18.4. Company Deep Dive

18.4.1. Sigma-Aldrich Co. LLC.

18.4.1.1. Overview

18.4.1.2. Product and Application Portfolio

18.4.1.3. Production Footprint

18.4.1.4. Sales Footprint

18.4.1.5. Channel Footprint

18.4.1.6. Strategy

18.4.1.6.1. Marketing Strategy

18.4.1.6.2. Product Strategy

18.4.1.6.3. Channel Strategy

18.4.2. QIAGEN N.V.

18.4.2.1. Overview

18.4.2.2. Product and Application Portfolio

18.4.2.3. Production Footprint

18.4.2.4. Sales Footprint

18.4.2.5. Channel Footprint

18.4.2.6. Strategy

18.4.2.6.1. Marketing Strategy

18.4.2.6.2. Product Strategy

18.4.2.6.3. Channel Strategy

18.4.3. Thermo Fisher Scientific Inc.

18.4.3.1. Overview

18.4.3.2. Product and Application Portfolio

18.4.3.3. Production Footprint

18.4.3.4. Sales Footprint

18.4.3.5. Channel Footprint

18.4.3.6. Strategy

18.4.3.6.1. Marketing Strategy

18.4.3.6.2. Product Strategy

18.4.3.6.3. Channel Strategy

18.4.4. Illumina, Inc.

18.4.4.1. Overview

18.4.4.2. Product and Application Portfolio

18.4.4.3. Production Footprint

18.4.4.4. Sales Footprint

18.4.4.5. Channel Footprint

18.4.4.6. Strategy

18.4.4.6.1. Marketing Strategy

18.4.4.6.2. Product Strategy

18.4.4.6.3. Channel Strategy

18.4.5. SYGNIS AG

18.4.5.1. Overview

18.4.5.2. Product and Application Portfolio

18.4.5.3. Production Footprint

18.4.5.4. Sales Footprint

18.4.5.5. Channel Footprint

18.4.5.6. Strategy

18.4.5.6.1. Marketing Strategy

18.4.5.6.2. Product Strategy

18.4.5.6.3. Channel Strategy

18.4.6. Active Motif, Inc.

18.4.6. Overview

18.4.6.2. Product and Application Portfolio

18.4.6.3. Production Footprint

18.4.6.4. Sales Footprint

18.4.6.5. Channel Footprint

18.4.6.6. Strategy

18.4.6.6.1. Marketing Strategy

18.4.6.6.2. Product Strategy

18.4.6.6.3. Channel Strategy

18.4.7. LGC Limited

18.4.7.1. Overview

18.4.7.2. Product and Application Portfolio

18.4.7.3. Production Footprint

18.4.7.4. Sales Footprint

18.4.7.5. Channel Footprint

18.4.7.6. Strategy

18.4.7.6.1. Marketing Strategy

18.4.7.6.2. Product Strategy

18.4.7.6.3. Channel Strategy

18.4.8. Yikon Genomics

18.4.8.1. Overview

18.4.8.2. Product and Application Portfolio

18.4.8.3. Production Footprint

18.4.8.4. Sales Footprint

18.4.8.5. Channel Footprint

18.4.8.6. Strategy

18.4.8.6.1. Marketing Strategy

18.4.8.6.2. Product Strategy

18.4.8.6.3. Channel Strategy

18.4.9. General Electric Company

18.4.9.1. Overview

18.4.9.2. Product and Application Portfolio

18.4.9.3. Production Footprint

18.4.9.4. Sales Footprint

18.4.9.5. Channel Footprint

18.4.9.6. Strategy

18.4.9.6.1. Marketing Strategy

18.4.9.6.2. Product Strategy

18.4.9.6.3. Channel Strategy

19. Global Whole Genome Amplification Market Analysis 2013–2017 and Forecast 2018–2028 By Region

19.1. Introduction / Key Findings

19.2. Historical Market Size (US$ Mn) Analysis By Region

19.2.1. North America

19.2.2. Western Europe

19.2.3. Eastern Europe

19.2.4. Latin America

19.2.5. Asia Pacific Excluding Japan

19.2.6. Japan

19.2.7. Middle East and Africa

19.3. Market Size (US$ Mn) Forecast By Region

19.4. Market Attractiveness Analysis By Region

20. Global Whole Genome Amplification Market Analysis 2013–2017 and Forecast 2018–2028, By Product Type

20.1. Introduction/Key Finding

20.2. Historical Market Size (US$ Mn) Trend Analysis By Product Type, 2013-2017

20.2.1. Single Cell WGA Kit

20.2.2. Complete WGA Kit

20.2.3. WGA Reamplification Kit

20.2.4. WGA and ChIP DNA Kit

20.2.5. DNA Amplification Kit

20.2.6. Others

20.3. Market Size (US$ Mn) Forecast By Product Type, 2018-2028

20.4. Market Attractiveness Analysis By Product Type

21. Global Whole Genome Amplification Market Analysis 2013–2017 and Forecast 2018–2028, By Application

21.1.Introduction/Key Finding

21.2. Historical Market Size (US$ Mn) Trend Analysis By Application, 2013-2017

21.2.1. Drug Discovery and Development

21.2.2. Disease Diagnosis

21.2.3. Agriculture and Veterinary Research

21.2.4. Forensics

21.2.5. Others

21.3.Market Size (US$ Mn) Forecast By Application, 2018-2028

21.4.Market Attractiveness Analysis By Application

22. Global Whole Genome Amplification Market Analysis 2013–2017 and Forecast 2018–2028, By End User

22.1.Introduction/Key Finding

22.2. Historical Market Size (US$ Mn) Trend Analysis By End User, 2013-2017

22.2.1. Pharmaceutical and Biotechnology Companies

22.2.2. Hospitals and Clinics

22.2.3. Contract Research Organization

22.2.4. Research and Academic Institutes

22.2.5. Others

22.3.Market Size (US$ Mn) Forecast By End User, 2018-2028

22.4.Market Attractiveness Analysis By End User

23. Global Whole Genome Amplification Market Analysis 2013–2017 and Forecast 2018–2028

23.1.Market Value Share Analysis By All Segment

23.2.Y-o-Y Growth Analysis By All Segment

23.3.Absolute $ Opportunity

24. Assumptions and Acronyms Used

25 . Research Methodology

Whole Genome Amplification Market Reports - List of Tables

Table 01: North America Whole Genome Amplification Market Size (US$ Mn) Analysis-2013–2017 and Forecast 2018–2028, By Country

Table 02: North America WGA Market Size (US$ Mn) Analysis-2013–2017 and Forecast 2018–2028, By Product Type

Table 03: North America Whole Genome Amplification Market Size Value (US$ Mn) Analysis-2013–2017 and Forecast 2018–2028, By Application

Table 04: North America Whole Genome Amplification Market Size Value (US$ Mn) Analysis-2013–2017 and Forecast 2018–2028, By End User

Table 05: Latin America Whole Genome Amplification Market Size (US$ Mn) Analysis-2013–2017 and Forecast 2018–2028, By Country

Table 06: Latin America WGA Market Size (US$ Mn) Analysis-2013–2017 and Forecast 2018–2028, By Product Type

Table 07: Latin America Whole Genome Amplification Market Size Value (US$ Mn) Analysis-2013–2017 and Forecast 2018–2028, By Application

Table 08: Latin America Whole Genome Amplification Market Size Value (US$ Mn) Analysis-2013–2017 and Forecast 2018–2028, By End User

Table 09: Western Europe Whole Genome Amplification Market Size (US$ Mn) Analysis-2013–2017 and Forecast 2018–2028, By Country

Table 10: Western Europe WGA Market Size (US$ Mn) Analysis-2013–2017 and Forecast 2018–2028, By Product Type

Table 11: Western Europe Whole Genome Amplification Market Size Value (US$ Mn) Analysis-2013–2017 and Forecast 2018–2028, By Application

Table 12: Western Europe Whole Genome Amplification Market Size Value (US$ Mn) Analysis-2013–2017 and Forecast 2018–2028, By End User

Table 13: Eastern Europe Whole Genome Amplification Market Size (US$ Mn) Analysis-2013–2017 and Forecast 2018–2028, By Country

Table 14: Eastern Europe WGA Market Size (US$ Mn) Analysis-2013–2017 and Forecast 2018–2028, By Product Type

Table 15: Eastern Europe Whole Genome Amplification Market Size Value (US$ Mn) Analysis-2013–2017 and Forecast 2018–2028, By Application

Table 16: Eastern Europe Whole Genome Amplification Market Size Value (US$ Mn) Analysis-2013–2017 and Forecast 2018–2028, By End User

Table 17: APEJ Whole Genome Amplification Market Size (US$ Mn) Analysis-2013–2017 and Forecast 2018–2028, By Country

Table 18: APEJ WGA Market Size (US$ Mn) Analysis-2013–2017 and Forecast 2018–2028, By Product Type

Table 19: APEJ Whole Genome Amplification Market Size Value (US$ Mn) Analysis-2013–2017 and Forecast 2018–2028, By Application

Table 20: APEJ Whole Genome Amplification Market Size Value (US$ Mn) Analysis-2013–2017 and Forecast 2018–2028, By End User

Table 21: Japan WGA Market Size (US$ Mn) Analysis-2013–2017 and Forecast 2018–2028, By Product Type

Table 22: Japan Whole Genome Amplification Market Size Value (US$ Mn) Analysis-2013–2017 and Forecast 2018–2028, By Application

Table 23: Japan Whole Genome Amplification Market Size Value (US$ Mn) Analysis-2013–2017 and Forecast 2018–2028, By End User

Table 24: MEA Whole Genome Amplification Market Size (US$ Mn) Analysis-2013–2017 and Forecast 2018–2028, By Country

Table 25: MEA WGA Market Size (US$ Mn) Analysis-2013–2017 and Forecast 2018–2028, By Product Type

Table 26: MEA Whole Genome Amplification Market Size Value (US$ Mn) Analysis-2013–2017 and Forecast 2018–2028, By Application

Table 27: MEA Whole Genome Amplification Market Size Value (US$ Mn) Analysis-2013–2017 and Forecast 2018–2028, By End User

Table 28: Global Whole Genome Amplification Market Size Value (US$ Mn) Analysis-2013–2017 and Forecast 2018–2028, By Region

Table 29: Global Whole Genome Amplification Market Size Value (US$ Mn) Analysis-2013–2017 and Forecast 2018–2028, By Product Type

Table 30: Global Whole Genome Amplification Market Size Value (US$ Mn) Analysis-2013–2017 and Forecast 2018–2028, By Application

Table 31: Global Whole Genome Amplification Market Size Value (US$ Mn) Analysis-2013–2017 and Forecast 2018–2028, By End User

Whole Genome Amplification Market Reports - List of Figures

Figure 01: North America Whole Genome Amplification Market Size Analysis, 2013–2017

Figure 02: North America Whole Genome Amplification Market Forecast, 2018–2028

Figure 03: North America WGA Market, Single Cell WGA Kit Market Size Analysis, 2013–2017

Figure 04: North America WGA Market, Single Cell WGA Kit Market Forecast, 2018–2028

Figure 05: North America WGA Market, Complete WGA Kit Market Size Analysis, 2013–2017

Figure 06: North America WGA Market, Complete WGA Kit Market Forecast, 2018–2028

Figure 07: North America WGA Market, WGA Reamplification Kit Market Size Analysis, 2013–2017

Figure 08: North America WGA Market, WGA Reamplification Kit Market Forecast, 2018–2028

Figure 09: North America WGA Market, WGA & Chip DNA Kit Market Size Analysis, 2013–2017

Figure 10: North America WGA Market, WGA & Chip DNA Kit Market Forecast, 2018–2028

Figure 11: North America WGA Market, Others Market Size Analysis, 2013–2017

Figure 12: North America WGA Market, Others Market Forecast, 2018–2028

Figure 13: North America WGA Market Size Analysis, By Drug Discovery & Development, 2013–2017

Figure 14: North America WGA Market Forecast, By Drug Discovery & Development, 2018–2028

Figure 15: North America WGA Market Size Analysis, By Disease Diagnosis ,2013–2017

Figure 16: North America WGA Market Forecast, By Disease Diagnosis, 2018–2028

Figure 17: North America WGA Market Size Analysis, By Agriculture & Veterinary Research 2013–2017

Figure 18: North America WGA Market Forecast, By Agriculture & Veterinary Research, 2018–2028

Figure 19: North America WGA Market Size Analysis, By Forensics, 2013–2017

Figure 20: North America WGA Market Size Analysis, By Forensics, 2018–2028

Figure 21: North America WGA Market, Others Market Size Analysis, 2013–2017

Figure 22: North America WGA Market, Others Market Forecast, 2018–2028

Figure 23: North America Whole Genome Amplification Market Attractiveness Analysis, By Country

Figure 24: North Whole Genome Amplification Market Attractiveness Analysis, By Product Type

Figure 25: North Whole Genome Amplification Market Attractiveness Analysis, By Application

Figure 26: North Whole Genome Amplification Market Attractiveness Analysis, By End User

Figure 27: Latin America Whole Genome Amplification Market Size Analysis, 2013–2017

Figure 28: Latin America Whole Genome Amplification Market Forecast, 2018–2028

Figure 29: Latin America WGA Market, Single Cell WGA Kit Market Size Analysis, 2013–2017

Figure 30: Latin America WGA Market, Single Cell WGA Kit Market Forecast, 2018–2028

Figure 31: Latin America WGA Market, Complete WGA Kit Market Size Analysis, 2013–2017

Figure 32: Latin America WGA Market, Complete WGA Kit Market Forecast, 2018–2028

Figure 33: Latin America WGA Market, WGA Reamplification Kit Market Size Analysis, 2013–2017

Figure 34: Latin America WGA Market, WGA Reamplification Kit Market Forecast, 2018–2028

Figure 35: Latin America WGA Market, WGA & Chip DNA Kit Market Size Analysis, 2013–2017

Figure 36: Latin America WGA Market, WGA & Chip DNA Kit Market Forecast, 2018–2028

Figure 37: Latin America WGA Market, Others Market Size Analysis, 2013–2017

Figure 38: Latin America WGA Market, Others Market Forecast, 2018–2028

Figure 39: Latin America WGA Market Size Analysis, By Drug Discovery & Development, 2013–2017

Figure 40: Latin America WGA Market Forecast, By Drug Discovery & Development, 2018–2028

Figure 41: Latin America WGA Market Size Analysis, By Disease Diagnosis ,2013–2017

Figure 42: Latin America WGA Market Forecast, By Disease Diagnosis, 2018–2028

Figure 43: Latin America WGA Market Size Analysis, By Agriculture & Veterinary Research 2013–2017

Figure 44: Latin America WGA Market Forecast, By Agriculture & Veterinary Research, 2018–2028

Figure 45: Latin America WGA Market Size Analysis, By Forensics, 2013–2017

Figure 46: Latin America WGA Market Size Analysis, By Forensics, 2018–2028

Figure 47: Latin America WGA Market, Others Market Size Analysis, 2013–2017

Figure 48: Latin America WGA Market, Others Market Forecast, 2018–2028

Figure 49: Latin America Whole Genome Amplification Market Attractiveness Analysis, By Country

Figure 50: Latin America Whole Genome Amplification Market Attractiveness Analysis, By Product Type

Figure 51: Latin America Whole Genome Amplification Market Attractiveness Analysis, By Application

Figure 52: Latin America Whole Genome Amplification Market Attractiveness Analysis, By End User

Figure 53: Western Europe Whole Genome Amplification Market Size Analysis, 2013–2017

Figure 54: Western Europe Whole Genome Amplification Market Forecast, 2018–2028

Figure 55: Western Europe WGA Market, Single Cell WGA Kit Market Size Analysis, 2013–2017

Figure 56: Western Europe WGA Market, Single Cell WGA Kit Market Forecast, 2018–2028

Figure 57: Western Europe WGA Market, Complete WGA Kit Market Size Analysis, 2013–2017

Figure 58: Western Europe WGA Market, Complete WGA Kit Market Forecast, 2018–2028

Figure 59: Western Europe WGA Market, WGA Reamplification Kit Market Size Analysis, 2013–2017

Figure 60: Western Europe WGA Market, WGA Reamplification Kit Market Forecast, 2018–2028

Figure 61: Western Europe WGA Market, WGA & Chip DNA Kit Market Size Analysis, 2013–2017

Figure 62: Western Europe WGA Market, WGA & Chip DNA Kit Market Forecast, 2018–2028

Figure 63: Western Europe WGA Market, Others Market Size Analysis, 2013–2017

Figure 64: Western Europe WGA Market, Others Market Forecast, 2018–2028

Figure 65: Western Europe WGA Market Size Analysis, By Drug Discovery & Development, 2013–2017

Figure 66: Western Europe WGA Market Forecast, By Drug Discovery & Development, 2018–2028

Figure 67: Western Europe WGA Market Size Analysis, By Disease Diagnosis ,2013–2017

Figure 68: Western Europe WGA Market Forecast, By Disease Diagnosis, 2018–2028

Figure 69: Western Europe WGA Market Size Analysis, By Agriculture & Veterinary Research 2013–2017

Figure 70: Western Europe WGA Market Forecast, By Agriculture & Veterinary Research, 2018–2028

Figure 71: Western Europe WGA Market Size Analysis, By Forensics, 2013–2017

Figure 72: Western Europe WGA Market Size Analysis, By Forensics, 2018–2028

Figure 73: Western Europe WGA Market, Others Market Size Analysis, 2013–2017

Figure 74: Western Europe WGA Market, Others Market Forecast, 2018–2028

Figure 75: Western Europe Whole Genome Amplification Market Attractiveness Analysis, By Country

Figure 76: Western Europe Whole Genome Amplification Market Attractiveness Analysis, By Product Type

Figure 77: Western Europe Whole Genome Amplification Market Attractiveness Analysis, By Application

Figure 78: Western Europe Whole Genome Amplification Market Attractiveness Analysis, By End User

Figure 79: Eastern Europe Whole Genome Amplification Market Size Analysis, 2013–2017

Figure 80: Eastern Europe Whole Genome Amplification Market Forecast, 2018–2028

Figure 81: Eastern Europe WGA Market, Single Cell WGA Kit Market Size Analysis, 2013–2017

Figure 82: Eastern Europe WGA Market, Single Cell WGA Kit Market Forecast, 2018–2028

Figure 83: Eastern Europe WGA Market, Complete WGA Kit Market Size Analysis, 2013–2017

Figure 84: Eastern Europe WGA Market, Complete WGA Kit Market Forecast, 2018–2028

Figure 85: Eastern Europe WGA Market, WGA Reamplification Kit Market Size Analysis, 2013–2017

Figure 86: Eastern Europe WGA Market, WGA Reamplification Kit Market Forecast, 2018–2028

Figure 87: Eastern Europe WGA Market, WGA & Chip DNA Kit Market Size Analysis, 2013–2017

Figure 88: Eastern Europe WGA Market, WGA & Chip DNA Kit Market Forecast, 2018–2028

Figure 89: Eastern Europe WGA Market, Others Market Size Analysis, 2013–2017

Figure 90: Eastern Europe WGA Market, Others Market Forecast, 2018–2028

Figure 91: Eastern Europe WGA Market Size Analysis, By Drug Discovery & Development, 2013–2017

Figure 92: Eastern Europe WGA Market Forecast, By Drug Discovery & Development, 2018–2028

Figure 93: Eastern Europe WGA Market Size Analysis, By Disease Diagnosis ,2013–2017

Figure 94: Eastern Europe WGA Market Forecast, By Disease Diagnosis, 2018–2028

Figure 95: Eastern Europe WGA Market Size Analysis, By Agriculture & Veterinary Research 2013–2017

Figure 96: Eastern Europe WGA Market Forecast, By Agriculture & Veterinary Research, 2018–2028

Figure 97: Eastern Europe WGA Market Size Analysis, By Forensics, 2013–2017

Figure 98: Eastern Europe WGA Market Size Analysis, By Forensics, 2018–2028

Figure 99: Eastern Europe WGA Market, Others Market Size Analysis, 2013–2017

Figure 100: Eastern Europe WGA Market, Others Market Forecast, 2018–2028

Figure 101: Eastern Europe Whole Genome Amplification Market Attractiveness Analysis, By Country

Figure 102: Eastern Europe Whole Genome Amplification Market Attractiveness Analysis, By Product Type

Figure 103: Eastern Europe Whole Genome Amplification Market Attractiveness Analysis, By Application

Figure 104: Eastern Europe Whole Genome Amplification Market Attractiveness Analysis, By End User

Figure 105: APEJ Whole Genome Amplification Market Size Analysis, 2013–2017

Figure 106: APEJ Whole Genome Amplification Market Forecast, 2018–2028

Figure 107: APEJ WGA Market, Single Cell WGA Kit Market Size Analysis, 2013–2017

Figure 108: APEJ WGA Market, Single Cell WGA Kit Market Forecast, 2018–2028

Figure 109: APEJ WGA Market, Complete WGA Kit Market Size Analysis, 2013–2017

Figure 110: APEJ WGA Market, Complete WGA Kit Market Forecast, 2018–2028

Figure 111: APEJ WGA Market, WGA Reamplification Kit Market Size Analysis, 2013–2017

Figure 112: APEJ WGA Market, WGA Reamplification Kit Market Forecast, 2018–2028

Figure 113: APEJ WGA Market, WGA & Chip DNA Kit Market Size Analysis, 2013–2017

Figure 114: APEJ WGA Market, WGA & Chip DNA Kit Market Forecast, 2018–2028

Figure 115: APEJ WGA Market, Others Market Size Analysis, 2013–2017

Figure 116: APEJ WGA Market, Others Market Forecast, 2018–2028

Figure 117: APEJ WGA Market Size Analysis, By Drug Discovery & Development, 2013–2017

Figure 118: APEJ WGA Market Forecast, By Drug Discovery & Development, 2018–2028

Figure 119: APEJ WGA Market Size Analysis, By Disease Diagnosis ,2013–2017

Figure 120: APEJ WGA Market Forecast, By Disease Diagnosis, 2018–2028

Figure 121: APEJ WGA Market Size Analysis, By Agriculture & Veterinary Research 2013–2017

Figure 122: APEJ WGA Market Forecast, By Agriculture & Veterinary Research, 2018–2028

Figure 123: APEJ WGA Market Size Analysis, By Forensics, 2013–2017

Figure 124: APEJ WGA Market Size Analysis, By Forensics, 2018–2028

Figure 125: APEJ WGA Market, Others Market Size Analysis, 2013–2017

Figure 126: APEJ WGA Market, Others Market Forecast, 2018–2028

Figure 127: APEJ Whole Genome Amplification Market Attractiveness Analysis, By Country

Figure 128: APEJ Whole Genome Amplification Market Attractiveness Analysis, By Product Type

Figure 129: APEJ Whole Genome Amplification Market Attractiveness Analysis, By Application

Figure 130: APEJ Whole Genome Amplification Market Attractiveness Analysis, By End User

Figure 131: Japan Whole Genome Amplification Market Size Analysis, 2013–2017

Figure 132: Japan Whole Genome Amplification Market Forecast, 2018–2028

Figure 133: Japan WGA Market, Single Cell WGA Kit Market Size Analysis, 2013–2017

Figure 134: Japan WGA Market, Single Cell WGA Kit Market Forecast, 2018–2028

Figure 135: Japan WGA Market, Complete WGA Kit Market Size Analysis, 2013–2017

Figure 136: Japan WGA Market, Complete WGA Kit Market Forecast, 2018–2028

Figure 137: Japan WGA Market, WGA Reamplification Kit Market Size Analysis, 2013–2017

Figure 138: Japan WGA Market, WGA Reamplification Kit Market Forecast, 2018–2028

Figure 139: Japan WGA Market, WGA & Chip DNA Kit Market Size Analysis, 2013–2017

Figure 140: Japan WGA Market, WGA & Chip DNA Kit Market Forecast, 2018–2028

Figure 141: Japan WGA Market, Others Market Size Analysis, 2013–2017

Figure 142: Japan WGA Market, Others Market Forecast, 2018–2028

Figure 143: Japan WGA Market Size Analysis, By Drug Discovery & Development, 2013–2017

Figure 144: Japan WGA Market Forecast, By Drug Discovery & Development, 2018–2028

Figure 145: Japan WGA Market Size Analysis, By Disease Diagnosis ,2013–2017

Figure 146: Japan WGA Market Forecast, By Disease Diagnosis, 2018–2028

Figure 147: Japan WGA Market Size Analysis, By Agriculture & Veterinary Research 2013–2017

Figure 148: Japan WGA Market Forecast, By Agriculture & Veterinary Research, 2018–2028

Figure 149: Japan WGA Market Size Analysis, By Forensics, 2013–2017

Figure 150: Japan WGA Market Size Analysis, By Forensics, 2018–2028

Figure 151: Japan WGA Market, Others Market Size Analysis, 2013–2017

Figure 152: Japan WGA Market, Others Market Forecast, 2018–2028

Figure 153: Japan Whole Genome Amplification Market Attractiveness Analysis, By Product Type

Figure 154: Japan Whole Genome Amplification Market Attractiveness Analysis, By Application

Figure 155: Japan Whole Genome Amplification Market Attractiveness Analysis, By End User

Figure 156: MEA Whole Genome Amplification Market Size Analysis, 2013–2017

Figure 157: MEA Whole Genome Amplification Market Forecast, 2018–2028

Figure 158: MEA WGA Market, Single Cell WGA Kit Market Size Analysis, 2013–2017

Figure 159: MEA WGA Market, Single Cell WGA Kit Market Forecast, 2018–2028

Figure 160: MEA WGA Market, Complete WGA Kit Market Size Analysis, 2013–2017

Figure 161: MEA WGA Market, Complete WGA Kit Market Forecast, 2018–2028

Figure 162: MEA WGA Market, WGA Reamplification Kit Market Size Analysis, 2013–2017

Figure 163: MEA WGA Market, WGA Reamplification Kit Market Forecast, 2018–2028

Figure 164: MEA WGA Market, WGA & Chip DNA Kit Market Size Analysis, 2013–2017

Figure 165: MEA WGA Market, WGA & Chip DNA Kit Market Forecast, 2018–2028

Figure 166: MEA WGA Market, Others Market Size Analysis, 2013–2017

Figure 167: MEA WGA Market, Others Market Forecast, 2018–2028

Figure 168: MEA WGA Market Size Analysis, By Drug Discovery & Development, 2013–2017

Figure 169: MEA WGA Market Forecast, By Drug Discovery & Development, 2018–2028

Figure 170: MEA WGA Market Size Analysis, By Disease Diagnosis ,2013–2017

Figure 171: MEA WGA Market Forecast, By Disease Diagnosis, 2018–2028

Figure 172: MEA WGA Market Size Analysis, By Agriculture & Veterinary Research 2013–2017

Figure 173: MEA WGA Market Forecast, By Agriculture & Veterinary Research, 2018–2028

Figure 174: MEA WGA Market Size Analysis, By Forensics, 2013–2017

Figure 175: MEA WGA Market Size Analysis, By Forensics, 2018–2028

Figure 176: MEA WGA Market, Others Market Size Analysis, 2013–2017

Figure 177: MEA WGA Market, Others Market Forecast, 2018–2028

Figure 178: MEA Whole Genome Amplification Market Attractiveness Analysis, By Country

Figure 179: MEA Whole Genome Amplification Market Attractiveness Analysis, By Product Type

Figure 180: MEA Whole Genome Amplification Market Attractiveness Analysis, By Application

Figure 181: MEA Whole Genome Amplification Market Attractiveness Analysis, By End User

Figure 182: Global Whole Genome Amplification Market Attractiveness Analysis By Region, 2018–2028 

Figure 183: Global Whole Genome Amplification Market Attractiveness Analysis By Product Type, 2018–2028 

Figure 184: Global Whole Genome Amplification Market Attractiveness Analysis By Application, 2018–2028 

Figure 185: Global Whole Genome Amplification Market Attractiveness Analysis By End User, 2018–2028 

Figure 186: Global Whole Genome Amplification Market Value Analysis and Forecast, 2016–2027 (US$ Mn)

Figure 187: Global Whole Genome Amplification Market Absolute $ Opportunity (US$ Mn), 2017–2028